Health
Covid-19 is Big Pharma’s chance to impress. But who’ll do best? – The Guardian
AstraZeneca and GSK both release results this week. But picking winners in the sector may be complicated
It was the press announcement heard around the world: a potential Covid-19 vaccine from the University of Oxford and pharmaceutical company AstraZeneca had not only been tolerated by patients, but generated robust immune responses against the Sars-CoV-2 virus in all evaluated participants. The project will now proceed to all-important phase 3 trials in Brazil and South Africa to test if it actually stops infection.
For a global population that has seen its movement curtailed and its health thre…
Continue Reading